12/1/22 16:16 | 11/29/22 | KNSA | Kiniksa Pharmaceuticals, Ltd. | D0 | Health | Drug | Pharmaceutical Preparations | Quart Barry D | D0 | D | | S.d | -355 | 16.15 | 0 | -22 | -100 | 0 | D | | | | | | | | | | | | | | |
6/22/18 21:35 | 6/21/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S.d | -1,953 | 39.05 | 0 | -50 | -42 | 70 | D | | | | | | | | | | | | | | |
3/19/18 19:22 | 3/19/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S.d | -2,975 | 29.75 | 0 | -100 | -60 | 68 | D | | | | | | | | | | | | | | |
3/16/18 21:00 | 3/14/18 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S.d | -2,475 | 24.75 | 0 | -100 | -60 | 68 | D | | | | | | | | | | | | | | |
3/4/15 18:52 | 3/2/15 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | CEO | S | -131 | 13.07 | 2 | -10 | -19 | 43 | D | -4 | -8 | 39 | 69 | 63 | 40 | 18 | 3 | 10 | 5 | 1 | 70 | 188 | 29 |
6/24/14 17:07 | 6/20/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | S.d | -138 | 100.00 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
6/19/14 17:28 | 6/17/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | S.d | -90 | 90.00 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
6/16/14 18:56 | 6/12/14 | GEVA | Synageva Biopharma Corp | DE | Health | BioPrd | Biological Products, (No Diag | Quart Barry D | MA | D | | S.d | -83 | 83.31 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
5/11/11 21:29 | 5/9/11 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -544 | 27.20 | 3 | -20 | -24 | 62 | D | 87 | 14 | 13 | 1 | -3 | -1 | -4 | -1 | -1 | -9 | -12 | -36 | -29 | |
2/9/11 21:28 | 2/7/11 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -535 | 26.77 | 5 | -20 | -24 | 62 | D | 108 | 84 | 34 | 12 | 1 | 0 | -2 | 0 | 3 | 1 | -1 | 3 | -34 | -27 |
12/10/10 21:41 | 12/8/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -438 | 21.92 | 2 | -20 | -30 | 47 | D | 146 | 47 | -2 | -4 | 3 | -1 | -1 | -1 | 1 | 14 | 36 | 18 | 4 | -17 |
8/10/10 19:39 | 8/9/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -404 | 20.21 | 2 | -20 | -32 | 42 | D | 46 | 4 | 42 | -6 | -6 | 9 | 6 | -2 | -4 | -6 | 9 | 17 | 33 | -16 |
5/7/10 21:50 | 5/7/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -530 | 21.20 | 6 | -25 | -38 | 42 | D | 69 | 82 | 65 | 55 | 22 | -9 | -10 | -12 | 6 | 13 | 4 | 0 | 8 | 29 |
2/10/10 16:30 | 2/8/10 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -364 | 14.57 | 1 | -25 | -38 | 42 | D | 3 | 13 | -27 | 7 | 1 | -4 | -1 | 0 | 0 | 0 | 15 | 63 | 37 | 84 |
12/11/09 17:09 | 12/9/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -362 | 14.48 | 2 | -25 | -54 | 22 | D | 9 | 56 | -5 | -21 | 3 | 14 | 2 | -1 | 0 | 3 | 10 | 26 | 59 | 54 |
8/13/09 20:20 | 8/11/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -483 | 19.33 | 2 | -25 | -49 | 27 | D | 203 | 40 | 60 | 43 | 26 | 5 | 2 | 4 | -3 | -5 | -12 | -35 | -30 | -8 |
5/21/09 21:02 | 5/19/09 | RDEA | Ardea Biosciences, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Quart Barry D | CA | DO | P,CEO | S.d | -385 | 15.39 | 1 | -25 | -49 | 27 | D | 204 | 8 | 59 | 6 | 63 | 22 | 4 | 5 | 0 | -2 | -2 | 30 | -16 | 48 |